无标题文档
current location: Home > News & Events
“Gaunrong Program”Comes to a Perfect Ending, with the First 20 Enterprises Settling Down in Songshan Lake
font size: Biginsmall date:2018-01-02 [Print this page]    [Close]

On the morning of December 27, Guanrong Program signing and plate awarding ceremony was officially held in Songshan Lake International Precision Medical Park, precisely located in the Songshan Lake-based Cross-Straits Biotech Industry Cooperation Base. At the ceremony, another 6 quality biotech enterprises signed up for the Guanrong Program to make the total up to 20, marking goal achievement and a perfect ending.

20 signed enterprises come from different subdivided biology industries.

Mr. Xuan Mingzhi, advisor of Guangdong Provincial Government, honorary deputy chairman of United Microelectronics Corporation (UMC) and president of Taiwan Cross-Straits Bioindustry Development Promotion Council, Mr. Song Tao, advisor of Dongguan Municipal Government and chairman of Dongguan Biotech Industry Development Co., Ltd., department leaders from Songshan Lake Management Committee and enterprise representatives of Guanrong Program, attended the event.

At the signing ceremony, Song formally signed contracts with 6 listed biotech enterprises, the last batch of enterprises that are selected into the Guanrong Program, namely Biostar Microtech Int'l Corp, TherMedic, Vetco Pharmaceuticals Inc., JJ Plus, Common Splendor International Health Industry Group Limited and Come True Biomedical (CTB). Soon afterwards, Song awarded plates to all these 20 enterprises signing up for the Guanrong Program, all of which will settle down in the Songshan Lake-based Cross-Straits Biotech Industry Cooperation Base.

These 20 signed enterprises, most of which have representative significance and some of which even play a leading role in Taiwan and Hong Kong, come from different subdivided biotech industries, including medical apparatus & instruments, in vitro diagnostic products (IVD), health food and cosmetics. Among them, Abnova Corporation, the world's largest antibody and recombinant protein manufacturer, is mainly engaged in research, development, production and sales of antibody and protein; Sunmax Biotechnology Co., Ltd is the only one across the Straits that has the capability to develop and manufacture collagen implants exclusively for plastic surgery; and Grape King Bio Ltd is the largest local health care products manufacturer in Tainwan, with an annual sales revenue exceeding TWD 10,000,000,000.00.

At the signing ceremony, Xuan introduced the overall situation of the implementation of the Guanrong Program over the recent three years. According to Xuan, Guanrong Program, through unremitting efforts of a professional team, has turned into widely known reality from simply a concept and has been highly recognized by a large number of high quality biotech enterprises. After rounds of audit, evaluation and selection by HukuiBio, Dongguan Biotech Industry Development Co., Ltd. and a team of experts, the first batch of 20 biotech companies were eventually introduced into Songshan Lake, accomplishing the goal set by Guanrong Program. These committed enterprises are expected to have greater support from Dongguan in the future for enhancing the biotech cooperation across the Straits.

 As Xuan indicated, an industrial transfer platform of such large size was rarely seen before and the successful implementation of and the good effect brought by Guanrong Program would certainly make Dongguan the best known demonstration district of cross-straits biotech industrial cooperation and boost a series of investment promotion activities. He also expected a cooperation model of higher level, wider range and deeper degree.

Best of the best were selected from a large number of listed companies.

As Song told the reporter, Guanrong Program as a creative means of investment attraction launched by the government, faced some difficulties in the early stage of promotion, because it was not just a matter of thinking about how to promote, but the most difficult thing was to choose the best of the best most of which were listed or public biotech companies. For this reason, in joint efforts with HukuiBio, Dongguan Biotech Industry Development Co., Ltd. made a great whoop and a holler about Guanrong Program in Taiwans biotech industry over the past three years, including media coverage, forums, exhibitions, investment promotion meetings, field trips, investigations and visits. More than 200 Taiwan-based biotech enterprises were contacted and investigated thoroughly. Guanrong Program has drawn high attention throughout the biotech industry in Taiwan.

In addition, Dongguan Biotech Industry Development Co., Ltd., as an implementing platform designated by the municipal government, has strict control over the selection of qualified enterprises and has established rigorous and prudent project evaluation process. Each selected project should undergo internal assessment, third-party due diligence, expert review and so on, and the normal operation of each settled down enterprise should be guaranteed through conclusion of cooperation contracts and defined product and technology import.


After three years of arduous efforts, the first batch of 20 high quality biotech enterprises were brought in Songshan Lake from Taiwan, which indicates Guanrong Program has been widely recognized by many enterprises and markets. Thanks to the favorable demonstration effect, more renowned biotech enterprises from Taiwan and Hong Kong have been attracted to Dongguan, including TURVO, Global Shengtai, Modern Dental Group and Mega. They have already or are going to set up a branch in Songshan Lake.

In Songs opinion, Guanrong Program is a biotech industrial transfer and exchange platform for enterprises between Dongguan and Taiwan. As implementation results show, a bunch of outstanding Taiwan-based biotech enterprises have been attracted by the Program and the practice is not only good for Dongguan-Taiwan cooperation, but also applicable to the cooperation between Dongguan and Singapore, Japan, the United States and other countries or regions. The success of Guanrong Program marks a new starting point of industrial cluster.

In addition to greater promotion of Guanrong Program and amplification of its brand effect, in the future more efforts will be concentrated on serving the rooted biotech enterprises, helping them to increase revenues and facilitate their stronger development in the Chinese Mainland. These biotech enterprises are willing to serve as a bridge of biotech exchange and cooperation between Dongguan and Taiwan. The recent successful cooperation between HEC Pharm and TaiGen Biotechnology has set a good example.

 

News source: Nanfang Daily

 


无标题文档